Company: STAA
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0000950170-25-058174
Chunk: 53

Company: STAAR SURGICAL CO
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 53
---
) In the case of a termination without Cause or for Good Reason without a Change in Control, severance payments reflect amounts for base salary (18 months for Mr. Frinzi, 12 months for Messrs. Williams and Foust and Dr. Michna, and 9 months for Mr. Sisitsky). For such a termination following a Change in Control, severance payments also include amounts for bonus (prior year and current year target bonus amounts paid out at 100% achievement). (4) As Mr. Frinzi declined health care benefits in 2024, no amounts are reflected for COBRA premiums. (5) Reflects acceleration of unvested stock options, RSUs, and PSUs based on a Company stock price of $24.21 per share (the closing price on December 27, 2024). PSUs with remaining performance conditions are presented assuming they are paid out at 100% of target.

| 2025 Proxy Statement | – 42 – |

EQUITY COMPENSATION PLAN INFORMATION The following table summarizes information about the equity compensation outstanding and the shares available for issuance under STAAR’s equity plans as of the close of business on December 27, 2024:

| Plan Category             |     | Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights (a) |    |     | Weighted Average Exercise Price of Outstanding Options, Warrants and Rights ($) (b) |    |     | Weighted Remaining Contractual Life of Outstanding Options, Warrants and Rights (c) |    |     |                                                                                                                             Number of 
 Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in column (a)) (d) |
| Equity Compensation Plans 
 Approved by Stockholders  |     |                                                                                       3,911,268 | -1 |     |                                                                               45.72 | -2 |     |                                                                                6.59 | -3 |     |                                                                                                                             3,438,028 |
| Equity Compensation Plans 
 Not Approved by           
 Stockholders              |     |                                                                                               — |    |     |                                                                                   — |    |     |                                                                                   — |    |     |                                                                                                                                     — |

(1) Represents awards granted under the Company’s Amended and Restated Omnibus Equity Incentive Plan, as amended. Consists of 2,808,579 options, 696,679 RSUs and 406,010 PSUs. PSUs with